The pharmaceutical market is highly responsible for the development and production of new drugs or medicines. North America occupies a major market share today. Furthermore, research conducted on vaccines, OTC drugs, and prescription drugs is driving the industry worldwide. Manufacturers are investing huge amounts on clinical trials to make sure developed medicine are tested. Innovations in drug delivery pattern and industry regulations has created opportunities for pharmaceutical market. Big Market Research reports analyze the current and the future trends of the industry. Important factors such as industry chain structure, upstream raw materials, and downstream customer market are also discussed in these reports. Extensive analysis of business environment across North America, Europe, Asia-Pacific and LAMEA forms an important part of these studies. Moreover, SWOT analysis conducted on key market players outline the strengths.
No of Reports 33510
HNY Research projects that the Sofosbuvir/Ledipasvir Compound Drugs market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Gilead Sciences, Natco Ltd, Zydus Cadila, Hetero Drugs, Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Cipla, Abbott, ...
HNY Research projects that the Pirfenidone market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals, Koye Pharmaceuticals, MSN Laborator...
HNY Research projects that the Nintedanib market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Boehringer Ingelheim Pharma By Application Locally Advanced NSCLC, Variant NSCLC, Locally Recurrent NSCLC By Type 100mg*10 Capsules, 150mg*10 Capsules,...
HNY Research projects that the Dolutegravir Sodium market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals, Cipla By Appl...
HNY Research projects that the Dolutegravir market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs, Adcock Ingram Limited By Application Prevent HIV Infecti...
HNY Research projects that the Raltegravir Potassium market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Merck, Cipla, Hetero Drugs By Application HIV-1 Infection, Other By Type Bottled Packaging, Film Coated Packaging The prime objective of th...
HNY Research projects that the Palbociclib market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Pfizer, Beacon Pharmaceuticals, Incepta Pharmaceuticals, Pharmaceuticals, Bluepharma, NANO DARU By Application Estrogen Receptor Positive (ER+) Breast ...
HNY Research projects that the Targeted Drugs for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Allergan, Amgen, ARIAD Pharmaceuticals (Takeda), Beacon Pharma Limited, BeiGene, Biocon, Boehringer-Ingelheim, Celgene Corporation, Drug In...
HNY Research projects that the Pirbuterol market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: 3M, Physicians Total Care, Graceway Pharmaceuticals, Medicis Pharmaceutical By Application Bronchial Asthma, Chronic Bronchitis, Emphysema, Other By Ty...
HNY Research projects that the Targeted Drug HER2 Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Boehringer-Ingelheim, Roche, Mylan, Biocon By Application By Type Afatinib, Trastuzumab, Other The prime objective of th...
HNY Research projects that the Targeted Drug ROS1 Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Roche, Pfizer, Beacon Pharma Limited, Drug International Limted, Incepta Pharmaceuticals By Application By Type Crizotini...
HNY Research projects that the Targeted Drug BRAF Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: BeiGene, Novartis By Application By Type Dabrafenib, Trametinib, Lifirafenib, Other The prime objective of this report i...
HNY Research projects that the Targeted Drug MEK Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Novartis By Application By Type Trametinib, Other The prime objective of this report is to help the user understand the m...
HNY Research projects that the Targeted Drug VEGFR2 Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: ImClone Systems (Eli Lilly) By Application By Type Ramucirumab, Other The prime objective of this report is to help...
HNY Research projects that the Targeted Drug VEGF Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Roche, Pfizer, Allergan, Amgen, Biocon, Reliance Lifesciences, Beaconpharma, Celgene Corporation, Fujifilm Kyowa Kirin Biolo...
HNY Research projects that the Crizotinib market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Pfizer, Beacon Pharma, Incepta Pharmaceuticals, Drug International By Application ALK Positive NSCLC, ROS1 Positive NSCLC By Type 250mg*60 Capsules, 20...
HNY Research projects that the Selective Cox-2 Inhibitors market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Meda Ph...
HNY Research projects that the Etodolac market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Amneal Pharmaceuticals, Genpharm Ulc, Physicians Total Care, Actavis Elizabeth, Blenheim Pharmacal, Teva, Taro Pharmaceuticals, Apotex, PD-Rx Pharmaceutica...
HNY Research projects that the Non-Peptide Drugs of Angiotensin II Receptor Antagonist market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Pfizer, Novartis, Merck, AstraZeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, G...
HNY Research projects that the Allisartan Isoproxil market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Shanghai Ailisi Medicine Technology, Shenzhen Salubris Pharmaceuticals By Application Mild Primary Hypertension, Moderate Primary Hypertension...
HNY Research projects that the Apatinib market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Advenchen Laboratories, Jiangsu Hengrui Medicine, LSK BioPartners, Bukwang Pharmaceutical Company By Application Metastatic Gastric Carcinoma, Metastatic ...
HNY Research projects that the PD-1 Inhibitor market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Merck, Novartis, Onxeo, Sumitomo Dainippon Pharma, Taiwan Liposome Company, Tiziana Life Sciences, Genentech (Roche), AstraZeneca, Pfizer By Applica...
HNY Research projects that the Nivolumab market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Ono Pharmaceutical, Bristol-Myers Squibb By Application Unresectable Melanoma, Metastatic Melanoma, Metastatic Squamous NSCLC, Classical Hodgkin Lymphoma...
HNY Research projects that the Durvalumab market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Medimmune (AstraZeneca) By Application Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Other By Type 2.4mL Injection, 10mL Inje...
HNY Research projects that the Pembrolizumab market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Merck By Application Advanced Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Unresectable or Metastatic Solid Tumor, Other By Type 50mg In...
HNY Research projects that the Avelumab market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Merck, Pfizer By Application Merkel-cell Carcinoma, Non-small Cell Lung Carcinoma (NSCLC), Other By Type Injection The prime objective of this report is...
HNY Research projects that the Targeted Drug EGFR RTK Inhibitors for NSCLC market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Beta Pharma, AstraZeneca, Natco Pharma, Qilu Pharmaceutical, Genentech (Roche Group), Mylan, Teva, OSI Pharmaceuticals, ...
HNY Research projects that the Imrecoxib market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Hengrui Pharmaceutical By Application Hospital, Clinic, Pharmacy, Other By Type 6 Pcs/Box, 10 Pcs/Box The prime objective of this report is to help the...
HNY Research projects that the Iguratimod market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Simcere Pharmaceutical, Toyama Chemical, Eisai By Application Antirheumatic, Immunoregulation, Other By Type 14 Pcs/Box, 100 Pcs/Box The prime objecti...
HNY Research projects that the Metoprolol Combination Drugs market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Novartis, Selokeen, Alphapharm, Arrow Pharmaceuticals, Astrazeneca, Unipharm, Berlin-Chemie AG By Application By Type Metoprolol Suc...